Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 677,387 $ (167) $ (470,038) $ 207,182
Balance, at beginning (in shares) at Dec. 31, 2022 6,446        
Repurchase of common stock under Share Repurchase Program, including transactional expenses of $334 (3) (13,962) (13,965)
Repurchase of common stock under share repurchase program, including transactional expenses of $334 (in shares) (836)        
Issuance of common stock under 2022 Purchase agreement 441 441
Issuance of common stock under 2022 Purchase agreement (in shares) 30        
Issuance of common stock under At-the-market offering, net of transactional expenses of $137 3,024 3,024
Issuance of common stock under At-the-market offering, net of transactional expenses of $137 (in shares) 322        
Issuance of common stock and warrants under AGP Financing, net of transactional expenses of $2,663 16,262 16,262
Issuance of common stock and warrants under AGP Financing, net of transactional expenses of $2,663 (in shares) 9,977        
Issuance of common stock upon exercise of prefunded common warrants
Issuance of common stock upon exercise of prefunded common warrants (in shares) 4,982        
Employee stock purchase plan 29 29
Employee stock purchase plan (in shares) 5        
Stock-based compensation 9,275 9,275
Foreign currency transaction gain (65) (65)
Net loss (116,658) (116,658)
Ending balance, value at Dec. 31, 2023 706,415 (232) (600,658) 105,525
Balance, at ending (in shares) at Dec. 31, 2023 20,926        
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock upon exercise of prefunded common warrants (in shares) 113,155        
Issuance of common stock under At-the-market offering, net of transactional expenses of $4,977 $ 4 128,363 128,367
Issuance of common stock under At-the-market offering, net of transactional expenses of $4,977 (in shares) 4,174,122        
Issuance of common stock, net of transactional expenses of $2,261 14,215 14,215
Issuance of common stock, net of transactional expenses of $2,261 (in shares) 77,635        
Fair value of warrants classified from equity to liabilities (9,977) (9,977)
Fair value of warrants reclassified from liabilities to equity 26,682 26,682
Employee stock purchase plan 27 27
Employee stock purchase plan (in shares) 91        
Stock-based compensation 4,778 4,778
Foreign currency transaction gain (23) (23)
Net loss (130,036) (130,036)
Ending balance, value at Dec. 31, 2024 $ 4 $ 870,503 $ (255) $ (730,694) $ 139,558
Balance, at ending (in shares) at Dec. 31, 2024 4,385,929